116 related articles for article (PubMed ID: 29751176)
1. IL-4 mediates the delayed neurobehavioral impairments induced by neonatal hepatitis B vaccination that involves the down-regulation of the IL-4 receptor in the hippocampus.
Wang X; Yang J; Xing Z; Zhang H; Wen Y; Qi F; Zuo Z; Xu J; Yao Z
Cytokine; 2018 Oct; 110():137-149. PubMed ID: 29751176
[TBL] [Abstract][Full Text] [Related]
2. Neonatal hepatitis B vaccination impaired the behavior and neurogenesis of mice transiently in early adulthood.
Yang J; Qi F; Yang Y; Yuan Q; Zou J; Guo K; Yao Z
Psychoneuroendocrinology; 2016 Nov; 73():166-176. PubMed ID: 27501128
[TBL] [Abstract][Full Text] [Related]
3. An enriched environment restores hepatitis B vaccination-mediated impairments in synaptic function through IFN-γ/Arginase1 signaling.
Qi F; Zuo Z; Hu S; Xia Y; Song D; Kong J; Yang Y; Wu Y; Wang X; Yang J; Hu D; Yuan Q; Zou J; Guo K; Xu J; Yao Z
Brain Behav Immun; 2018 Jul; 71():116-132. PubMed ID: 29627530
[TBL] [Abstract][Full Text] [Related]
4. [Effect of interleukin-6 and interleukin-12 on immune response to hepatitis B vaccination in infants of HBsAg-positive mothers].
Wang XF; Shi XH; Xu XX; Yang ZQ; Hao HY; Zhang F; Wang B; Wen HX; Fu ZD; Wang T; Feng SY; Wang B; Wang SP
Zhonghua Liu Xing Bing Xue Za Zhi; 2017 Jul; 38(7):950-953. PubMed ID: 28738472
[No Abstract] [Full Text] [Related]
5. IL-12-based vaccination therapy reverses liver-induced systemic tolerance in a mouse model of hepatitis B virus carrier.
Zeng Z; Kong X; Li F; Wei H; Sun R; Tian Z
J Immunol; 2013 Oct; 191(8):4184-93. PubMed ID: 24048897
[TBL] [Abstract][Full Text] [Related]
6. Neonatal Bacillus Calmette-Guérin vaccination alleviates lipopolysaccharide-induced neurobehavioral impairments and neuroinflammation in adult mice.
Yang J; Qi F; Yao Z
Mol Med Rep; 2016 Aug; 14(2):1574-86. PubMed ID: 27357155
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis B vaccination and central nervous system demyelination: an immunological approach.
Piaggio E; Ben Younes A; Desbois S; Gout O; Tourbah A; Lyon-Caen O; Liblau RS
J Autoimmun; 2005 Feb; 24(1):33-7. PubMed ID: 15725574
[TBL] [Abstract][Full Text] [Related]
8. Lasting immune memory against hepatitis B following challenge 10-11 years after primary vaccination with either three doses of hexavalent DTPa-HBV-IPV/Hib or monovalent hepatitis B vaccine at 3, 5 and 11-12 months of age.
Avdicova M; Crasta PD; Hardt K; Kovac M
Vaccine; 2015 May; 33(23):2727-33. PubMed ID: 24962750
[TBL] [Abstract][Full Text] [Related]
9. [Relationship between the mode of HBV marker and immune status in neonates and non-/hyporesponse to hepatitis B vaccine].
Zhang F; Wang SP; Shi XH; Wang XF; Gao Y; Guo J; Zhang LR; Wang T; Wen HX; Xu XX; Yang ZQ; Wang B; Wang B; Feng SY
Zhonghua Liu Xing Bing Xue Za Zhi; 2016 Aug; 37(8):1074-9. PubMed ID: 27539335
[TBL] [Abstract][Full Text] [Related]
10. Overcoming HBV immune tolerance to eliminate HBsAg-positive hepatocytes via pre-administration of GM-CSF as a novel adjuvant for a hepatitis B vaccine in HBV transgenic mice.
Wang X; Dong A; Xiao J; Zhou X; Mi H; Xu H; Zhang J; Wang B
Cell Mol Immunol; 2016 Nov; 13(6):850-861. PubMed ID: 26166767
[TBL] [Abstract][Full Text] [Related]
11. Serological and molecular epidemiological outcomes after two decades of universal infant hepatitis B virus (HBV) vaccination in Nunavut, Canada.
Huynh C; Minuk GY; Uhanova J; Baikie M; Wong T; Osiowy C
Vaccine; 2017 Aug; 35(35 Pt B):4515-4522. PubMed ID: 28736196
[TBL] [Abstract][Full Text] [Related]
12. Cloning, protein expression and immunogenicity of HBs-murine IL-18 fusion DNA vaccine.
Channarong S; Mitrevej A; Sinchaipanid N; Usuwantim K; Kulkeaw K; Chaicumpa W
Asian Pac J Allergy Immunol; 2007 Dec; 25(4):233-42. PubMed ID: 18402297
[TBL] [Abstract][Full Text] [Related]
13. Neonatal IL-4 Over-Exposure is Accompanied by Macrophage Accumulation in Dura Mater After Instant Anti-inflammatory Cytokine Response in CSF.
Wang L; Sha H; He X; Xie Y; Deng J; Chen J; Li G; Yang J
Cell Mol Neurobiol; 2024 Feb; 44(1):18. PubMed ID: 38315435
[TBL] [Abstract][Full Text] [Related]
14. [Analysis on the adverse events following immunization of 10 infants death after hepatitis B vaccination].
Wang FZ; Cui FQ; Liu DW
Zhongguo Yi Miao He Mian Yi; 2009 Feb; 15(1):52-7. PubMed ID: 20077677
[TBL] [Abstract][Full Text] [Related]
15. A novel dendritic-cell-targeting DNA vaccine for hepatitis B induces T cell and humoral immune responses and potentiates the antivirus activity in HBV transgenic mice.
Yu D; Liu H; Shi S; Dong L; Wang H; Wu N; Gao H; Cheng Z; Zheng Q; Cai J; Zou L; Zou Z
Immunol Lett; 2015 Dec; 168(2):293-9. PubMed ID: 26475398
[TBL] [Abstract][Full Text] [Related]
16. HBV DNA vaccine with adjuvant cytokines induced specific immune responses against HBV infection.
Du DW; Jia ZS; Li GY; Zhou YY
World J Gastroenterol; 2003 Jan; 9(1):108-11. PubMed ID: 12508362
[TBL] [Abstract][Full Text] [Related]
17. Unsolved problems and future perspectives of hepatitis B virus vaccination.
Tajiri K; Shimizu Y
World J Gastroenterol; 2015 Jun; 21(23):7074-83. PubMed ID: 26109794
[TBL] [Abstract][Full Text] [Related]
18. Significance and anamnestic response in isolated hepatitis B core antibody-positive individuals 18 years after neonatal hepatitis B virus vaccination in Taiwan.
Su FH; Bai CH; Chu FY; Lin YS; Su CT; Yeh CC
Vaccine; 2012 Jun; 30(27):4034-9. PubMed ID: 22531558
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis B virus serologic markers and anti-hepatitis B vaccination in patients with diabetes.
Halota W; Muszyńska M; Pawłowska M
Med Sci Monit; 2002 Jul; 8(7):CR516-9. PubMed ID: 12118201
[TBL] [Abstract][Full Text] [Related]
20. Effect of the hepatitis B virus S‑ecdCD40L vaccine therapy in HBV transgenic mice: A vaccine‑induced activation of antigen presenting dendritic cells.
Guan H; Lan S; Wu J; Tang B; Xu Y
Mol Med Rep; 2017 Nov; 16(5):6102-6108. PubMed ID: 28849136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
